Tag Archives: cardiovascular diseases

December, 2016

• 12 December

  Bayer and Versant Ventures Team up to Launch Stem Cell Therapy Company BlueRock Therapeutics with $225 Million Financing

  

  LEVERKUSEN, Germany and BOSTON and NEW YORK and TORONTO and KYOTO, Japan, Dec. 12, 2016 /PRNewswire/ — Bayer AG and Versant Ventures today announced the launch of BlueRock Therapeutics, a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of …

  Share

  • Facebook
  • Twitter
  • LinkedIn

April, 2015

• 6 April

  Bristol-Myers Squibb Enters Gene Therapy Deal with uniQure

  

  Today, Bristol-Myers Squibb (BMS) announced that it has entered into a deal with uniQure for its gene therapy technology platform. The companies said that they have entered into an agreement that provides BMS with exclusive access to uniQure’s technology platform for multiple targets in cardiovascular diseases, as well as the …

  Share

  • Facebook
  • Twitter
  • LinkedIn